Wells Fargo’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9 | Hold |
2
| – | – | ﹤0.01% | 6958 |
|
|
2025
Q4 | $27 | Hold |
2
| – | – | ﹤0.01% | 6665 |
|
|
2025
Q3 | $36 | Sell |
2
-12
| -86% | -$147 | ﹤0.01% | 6561 |
|
|
2025
Q2 | $124 | Buy |
+14
| New | +$183 | ﹤0.01% | 6465 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$63 | – | 7340 |
|
|
2024
Q1 | $63 | Hold |
1
| – | – | ﹤0.01% | 6771 |
|
|
2023
Q4 | $61 | Hold |
1
| – | – | ﹤0.01% | 6890 |
|
|
2023
Q3 | $28 | Hold |
1
| – | – | ﹤0.01% | 7095 |
|
|
2023
Q2 | $36 | Hold |
1
| – | – | ﹤0.01% | 7139 |
|
|
2023
Q1 | $68 | Hold |
1
| – | – | ﹤0.01% | 7026 |
|
|
2022
Q4 | $73 | Buy |
+1
| New | +$159 | ﹤0.01% | 6883 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7203 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7328 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7644 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7674 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7384 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7311 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7259 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6889 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6759 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6693 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | -$2.31K | – | 6659 |
|
|
2019
Q4 | $2K | Buy |
+3
| New | +$2.75K | ﹤0.01% | 6180 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6626 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6557 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6366 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6566 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6531 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6511 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6524 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6483 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6432 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6129 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6231 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6171 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6114 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6018 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6039 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6017 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5893 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5661 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5387 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5632 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 5509 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4987 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5021 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5091 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4410 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 4461 |
|
Other funds holding PSTV
VCM
VFT
TSS
XT
Wells Fargo's PSTV Position: Q1 2026 in Review
Wells Fargo held its Plus Therapeutics (PSTV) position steady in Q1 2026 at 2 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #6958.
Wells Fargo first reported a position in PSTV in Q4 2019 and has held it in 11 quarters since. The position peaked at $2K in Q4 2019. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.
- Wells Fargo held 2 shares of Plus Therapeutics worth $9 as of Q1 2026.
- Wells Fargo left its Plus Therapeutics share count unchanged in Q1 2026.
- Plus Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6958 holding.
- Wells Fargo first reported a position in Plus Therapeutics in Q4 2019 and has held it in 11 quarters since.
- Wells Fargo's Plus Therapeutics position peaked at $2K in Q4 2019.
- 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.